Jazz Pharmaceuticals Webinar
Rising to the Challenge of Veno-occlusive Disease (VOD): Advances in the Treatment of Post–hematopoietic Stem-Cell Transplantation (HSCT)
Originally presented December 13, 2017
View this webinar to gain a better understanding of VOD and treatment with Defitelio® (defibrotide sodium), the first and only approved medication for VOD with renal or pulmonary dysfunction post-HSCT.
Katie S. Gatwood, PharmD, BCOP
Clinical Pharmacist, Stem Cell Transplant
Vanderbilt University Medical Center
- Understand VOD pathogenesis and risk factors
- Recognize VOD and the initial signs and symptoms of renal or pulmonary dysfunction
- Discuss proposed mechanism of action, clinical efficacy, and safety of Defitelio
- Review Defitelio dosing and administration
This free event is open to HOPA members and non-members.
Please note: There are no certified continuing education credits approved for this program.
Listen to this webinar.
Please click here for full Prescribing Information for Defitelio.
Questions about this webinar can be directed to: